Liom
an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable
Liom has raised €14M across 1 funding round from 4 investors, most recently a Series A round in Dec 2025. Based in Schwyz, Switzerland; active in Wellness & Beauty. Data as of 28 Oct 2026.
Schwyz, Switzerlandliom.com ↗
Total raised
€14M
€13,900,000
Funding rounds
1
Investors
4
distinct backers
Active since
2025-12
latest 2025-12
Funding by year
EUR raised per yearLiom — funding by year — interactive chart.
Data table
| Liom — funding by year | |
|---|---|
| 2025 | €14M |
Signals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-19 | Series A | €14M | Alejo Costa Ribalta,Marc Maurer,Melih Odemis,Red Bull Ventures | View deal → |
Related news
Similar companies
same sector or country- Roivant Sciences€1.1BSwitzerland · Healthtech
- Climeworks€919MSwitzerland · Cleantech
- Energy Vault€898MSwitzerland · Energy
- ABB E-mobility€705MSwitzerland · Energy
- Green€488MSwitzerland · Telecom
- Kandou€470MSwitzerland · Semiconductors
Global coverage: FundingData